News
$65 million in funding resuscitates NeoRx
February 3, 2006 /
The NeoRx of two years ago would hardly recognize itself today: new management, 40 percent fewer employees, a single cancer drug in development, and, this week, fresh money.
The Seattle company announced a $65 million infusion of private capital Wednesday, staving off insolvency and prolonging its life for another five years at its current spending rate.
By Benjamin J. Romano
Seattle Times business reporter
Full Story: http://seattletimes.nwsource.com/html/businesstechnology/2002780071_neorx03.html
MATR Supporters (view all)
Posted in: Washington State Business
Sorry, we couldn't find any posts. Please try a different search.